Biomarker-driven early clinical trials in oncology: A paradigm shift in drug development

Daniel S.W. Tan, George V. Thomas, Michelle D. Garrett, Udai Banerji, Johann S. De Bono, Stan B. Kaye, Paul Workman

Research output: Contribution to journal › Review article › peer-review